NSIVX Mutual Fund

NSIVX Mutual Fund

NAV$13.55
See how much of NSIVX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Aug 31, 2026

Net Assets
$79M
Expense Ratio
0.97%
Dividend Yield (Current)
9.91%
Holdings
66
Inception Date
Dec 4, 2020
Fund Family
North Square
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+10.65%
1 Year+14.40%
3 Year+16.77%
5 Year+8.54%

Asset Allocation

Stocks: 96.84%
Cash: 3.16%
See how much of NSIVX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
CBChubb Ltd.3.48%
DB1GN:FFDeutsche Boerse Ag3.22%
FXFXXFirst Am Treas Obli-X3.15%
EGEverest Group Ltd Common Stock2.83%
6758:JPSony Group Corp.2.66%
Top 10 Concentration: 27.01%Report Date: Aug 31, 2026
Download all 66 holdings for NSIVX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
9.91%
Frequency
Annually

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

NSIVX Mutual Fund Overview

NSIVX Mutual Fund (North Square Altrinsic International Equity Fund Class I) is managed by North Square with $78.7M in net assets. NSIVX expense ratio is 0.97%, holding 66 positions across sectors including Financials, Health Care, Industrials. Inception date: 2020-12-04.

NSIVX performance shows a YTD return of 10.65%. The 1-year return is 14.40% and the 5-year return is 8.54%. NSIVX dividend yield stands at 9.91%, paid annually.

NSIVX top holdings include Chubb Ltd. (3.5%), Deutsche Boerse Ag (3.2%), First Am Treas Obli-X (3.1%), Everest Group Ltd Common Stock (2.8%), Sony Group Corp. (2.7%). Go to all NSIVX holdings, NSIVX sectors, or NSIVX dividends.

NSIVX can be compared against other funds. Use NSIVX overlap to find shared positions, or NSIVX vs another fund for a side-by-side view. NSIVX alternatives are available via the screener, along with tax-loss harvesting opportunities.